{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:00:20Z","timestamp":1785596420737,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T00:00:00Z","timestamp":1334102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s12149-012-0599-y","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T05:37:18Z","timestamp":1334036238000},"page":"492-500","source":"Crossref","is-referenced-by-count":36,"title":["Dual-time-point 18F-FDG PET\/CT in patients with colorectal cancer: clinical value of early delayed scanning"],"prefix":"10.1007","volume":"26","author":[{"given":"Kanae K.","family":"Miyake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,11]]},"reference":[{"key":"599_CR1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s00259-006-0319-8","volume":"34","author":"LG Strauss","year":"2007","unstructured":"Strauss LG, Klippel S, Pan L, Schonleben K, Haberkorn U, Dimitrakopoulou-Strauss A. Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection? Eur J Nucl Med Mol Imaging. 2007;34:868\u201377.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"599_CR2","first-page":"633","volume":"47","author":"Y Nishiyama","year":"2006","unstructured":"Nishiyama Y, Yamamoto Y, Fukunaga K, Kimura N, Miki A, Sasakawa Y, et al. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med. 2006;47:633\u20138.","journal-title":"J Nucl Med"},{"key":"599_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11547-009-0491-6","volume":"115","author":"MG Caprio","year":"2010","unstructured":"Caprio MG, Cangiano A, Imbriaco M, Soscia F, Di Martino G, Farina A, et al. Dual-time-point [18F]-FDG PET\/CT in the diagnostic evaluation of suspicious breast lesions. Radiol Med. 2010;115:215\u201324.","journal-title":"Radiol Med"},{"key":"599_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00256-008-0643-0","volume":"38","author":"R Tian","year":"2009","unstructured":"Tian R, Su M, Tian Y, Li F, Li L, Kuang A, et al. Dual-time point PET\/CT with F-18 FDG for the differentiation of malignant and benign bone lesions. Skeletal Radiol. 2009;38:451\u20138.","journal-title":"Skeletal Radiol"},{"key":"599_CR5","first-page":"540","volume":"44","author":"Y Demura","year":"2003","unstructured":"Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540\u20138.","journal-title":"J Nucl Med"},{"key":"599_CR6","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/1097-0142(20001215)89:12<2547::AID-CNCR5>3.0.CO;2-V","volume":"89","author":"Y Nakamoto","year":"2000","unstructured":"Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Doi R, et al. Delayed (18)F-fluoro-2-deoxy-d-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer. 2000;89:2547\u201354.","journal-title":"Cancer"},{"key":"599_CR7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s002590100537","volume":"28","author":"K Kubota","year":"2001","unstructured":"Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med. 2001;28:696\u2013703.","journal-title":"Eur J Nucl Med"},{"key":"599_CR8","first-page":"143","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 143\u201364.","edition":"7"},{"key":"599_CR9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2214\/ajr.185.2.01850495","volume":"185","author":"F Gutman","year":"2005","unstructured":"Gutman F, Alberini JL, Wartski M, Vilain D, Le Stanc E, Sarandi F, et al. Incidental colonic focal lesions detected by FDG PET\/CT. Am J Roentgenol. 2005;185:495\u2013500.","journal-title":"Am J Roentgenol"},{"key":"599_CR10","first-page":"758","volume":"46","author":"O Israel","year":"2005","unstructured":"Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET\/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46:758\u201362.","journal-title":"J Nucl Med"},{"key":"599_CR11","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s002590100645","volume":"28","author":"JP Drenth","year":"2001","unstructured":"Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med. 2001;28:1766\u20139.","journal-title":"Eur J Nucl Med"},{"key":"599_CR12","doi-asserted-by":"crossref","first-page":"W401","DOI":"10.2214\/AJR.09.3703","volume":"194","author":"PL Kei","year":"2010","unstructured":"Kei PL, Vikram R, Yeung HW, Stroehlein JR, Macapinlac HA. Incidental finding of focal FDG uptake in the bowel during PET\/CT: CT features and correlation with histopathologic results. Am J Roentgenol. 2010;194:W401\u20136.","journal-title":"Am J Roentgenol"},{"key":"599_CR13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2243011214","volume":"224","author":"R Tatlidil","year":"2002","unstructured":"Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002;224:783\u20137.","journal-title":"Radiology"},{"key":"599_CR14","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1148\/rg.245035725","volume":"24","author":"L Kostakoglu","year":"2004","unstructured":"Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics. 2004;24:1411\u201331.","journal-title":"Radiographics"},{"key":"599_CR15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0001-2998(96)80006-7","volume":"26","author":"GJ Cook","year":"1996","unstructured":"Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308\u201314.","journal-title":"Semin Nucl Med"},{"key":"599_CR16","first-page":"1804","volume":"45","author":"EM Kamel","year":"2004","unstructured":"Kamel EM, Thumshirn M, Truninger K, Schiesser M, Fried M, Padberg B, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET\/CT: correlation with endoscopic and histopathologic results. J Nucl Med. 2004;45:1804\u201310.","journal-title":"J Nucl Med"},{"key":"599_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1148\/radiographics.19.1.g99ja0761","volume":"19","author":"PD Shreve","year":"1999","unstructured":"Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61\u201377.","journal-title":"Radiographics"},{"key":"599_CR18","first-page":"989","volume":"42","author":"S Yasuda","year":"2001","unstructured":"Yasuda S, Fujii H, Nakahara T, Nishiumi N, Takahashi W, Ide M, et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med. 2001;42:989\u201392.","journal-title":"J Nucl Med"},{"key":"599_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2967\/jnumed.109.071001","volume":"51","author":"JD Soyka","year":"2010","unstructured":"Soyka JD, Strobel K, Veit-Haibach P, Schaefer NG, Schmid DT, Tschopp A, et al. Influence of bowel preparation before 18F-FDG PET\/CT on physiologic 18F-FDG activity in the intestine. J Nucl Med. 2010;51:507\u201310.","journal-title":"J Nucl Med"},{"key":"599_CR20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0038-1632274","volume":"39","author":"A Stahl","year":"2000","unstructured":"Stahl A, Weber WA, Avril N, Schwaiger M. Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen. Nuklearmedizin. 2000;39:241\u20135.","journal-title":"Nuklearmedizin"},{"key":"599_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MNM.0b013e3282f1d706","volume":"29","author":"J Emmott","year":"2008","unstructured":"Emmott J, Sanghera B, Chambers J, Wong WL. The effects of N-butylscopolamine on bowel uptake: an 18F-FDG PET study. Nucl Med Commun. 2008;29:11\u20136.","journal-title":"Nucl Med Commun"},{"key":"599_CR22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11307-008-0178-8","volume":"11","author":"R Murphy","year":"2009","unstructured":"Murphy R, Doerger KM, Nathan MA, Lowe VJ. Pretreatment with diphenoxylate hydrochloride\/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET\/CT scans of the abdomen and pelvis. Mol Imaging Biol. 2009;11:114\u20137.","journal-title":"Mol Imaging Biol"},{"key":"599_CR23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1148\/radiol.11101193","volume":"259","author":"YK Chen","year":"2011","unstructured":"Chen YK, Chen JH, Tsui CC, Chou HH, Cheng RH, Chiu JS. Use of laxative-augmented contrast medium in the evaluation of colorectal foci at FDG PET. Radiology. 2011;259:525\u201333.","journal-title":"Radiology"},{"key":"599_CR24","first-page":"1412","volume":"42","author":"H Zhuang","year":"2001","unstructured":"Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412\u20137.","journal-title":"J Nucl Med"},{"key":"599_CR25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12149-010-0439-x","volume":"25","author":"A Toriihara","year":"2010","unstructured":"Toriihara A, Yoshida K, Umehara I, Shibuya H. Normal variants of bowel FDG uptake in dual-time-point PET\/CT imaging. Ann Nucl Med. 2010;25:173\u20138.","journal-title":"Ann Nucl Med"},{"key":"599_CR26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.206.3.9494497","volume":"206","author":"H Abdel-Nabi","year":"1998","unstructured":"Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology. 1998;206:755\u201360.","journal-title":"Radiology"},{"key":"599_CR27","first-page":"85","volume":"7","author":"M Mukai","year":"2000","unstructured":"Mukai M, Sadahiro S, Yasuda S, Ishida H, Tokunaga N, Tajima T, et al. Preoperative evaluation by whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer. Oncol Rep. 2000;7:85\u20137.","journal-title":"Oncol Rep"},{"key":"599_CR28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00261-007-9262-9","volume":"33","author":"SS Shin","year":"2008","unstructured":"Shin SS, Jeong YY, Min JJ, Kim HR, Chung TW, Kang HK. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET\/CT. Abdom Imaging. 2008;33:270\u20137.","journal-title":"Abdom Imaging"},{"key":"599_CR29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF02238010","volume":"43","author":"MH Whiteford","year":"2000","unstructured":"Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000;43:759\u201367.","journal-title":"Dis Colon Rectum"},{"key":"599_CR30","first-page":"1784","volume":"44","author":"I Kantorova","year":"2003","unstructured":"Kantorova I, Lipska L, Belohlavek O, Visokai V, Trubac M, Schneiderova M. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med. 2003;44:1784\u20138.","journal-title":"J Nucl Med"},{"key":"599_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/ejso.2000.1075","volume":"27","author":"B Topal","year":"2001","unstructured":"Topal B, Flamen P, Aerts R, D\u2019Hoore A, Filez L, Van Cutsem E, et al. Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases. Eur J Surg Oncol. 2001;27:175\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"599_CR32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF02303744","volume":"4","author":"OA Ogunbiyi","year":"1997","unstructured":"Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol. 1997;4:613\u201320.","journal-title":"Ann Surg Oncol"},{"key":"599_CR33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.sla.0000146145.69835.c5","volume":"240","author":"M Selzner","year":"2004","unstructured":"Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET\/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg. 2004;240:1027\u201334.","journal-title":"Ann Surg"},{"key":"599_CR34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1200\/JCO.20.2.388","volume":"20","author":"TJ Ruers","year":"2002","unstructured":"Ruers TJ, Langenhoff BS, Neeleman N, Jager GJ, Strijk S, Wobbes T, et al. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol. 2002;20:388\u201395.","journal-title":"J Clin Oncol"},{"key":"599_CR35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0002-9610(99)00187-7","volume":"178","author":"Y Fong","year":"1999","unstructured":"Fong Y, Saldinger PF, Akhurst T, Macapinlac H, Yeung H, Finn RD, et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg. 1999;178:282\u20137.","journal-title":"Am J Surg"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-012-0599-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-012-0599-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-012-0599-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T03:14:20Z","timestamp":1561605260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-012-0599-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1007\/s12149-012-0599-y","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,11]]}}}